Key Record Dates
| ClinicalTrials.gov Identifier: | NCT05945368 |
|---|---|
| Brief Title: | A Trial of Eribulin in Combination With HP Neoadjuvant Therapy in Patients With for HER2-Positive BC |
| First Submitted : | May 28, 2023 |
| First Submitted that Met QC Criteria : | July 13, 2023 |
| First Posted : | July 14, 2023 |
| Last Update Submitted that Met QC Criteria : | July 13, 2023 |
| Last Update Posted : | July 14, 2023 |